Recent News & Comments About approved fda loss pill weight
Vivus Rises on FDA-Ordered Change to Weight-Loss Pill Label
Vivus Inc. (VVUS) , maker of experimental weight-loss pill Qnexa, jumped the most in 13 months after U.S. regulators ordered changes to a proposed warning label that may mean more women would be able to take the drug.
FDA approves Roche skin cancer drug Erivedge
Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.The pill is called Erivedge and is made by Genentech, a unit of Swiss drugmaker Roche. ...
Skin Cancer Drug Erivedge Approved
The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring or metastatic basal cell carcinoma (BCC) tumors.
FDA approves pill for most common type of skin cancer
The FDA has approved a new drug called Erivedge to treat basal cell carcinoma, the most common form of skin cancer. Federal regulators announced Monday the approval of the Erivedge pill, the first drug ever approved for treating basal cell carcinoma.
Skin-cancer drug tested in Valley approved by FDA
A new FDA-approved drug gives hope to patients with a type of advanced skin cancer.
FDA approves Erivedge for most common type of skin cancer
Pill is first drug ever approved to treat basal cell carcinoma; BCC strikes 2.8 million Americans each year
FDA Approves New Skin Cancer Drug
(AP) - Regulators have approved a pill that treats the most common type of skin cancer, basal cell carcinoma. The pill is called Erivedge and is made by Genentech, a unit of Swiss drugmaker Roche.
FDA approves Genentech's Erivedge, first drug to treat advanced form of most common type of skin cancer
Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
FDA approves new skin cancer pill
The US Food and Drug Administration has approved a new drug, called Erivedge, for the most common type of skin cancer, basal cell carcinoma. read more
Certain Diabetes Drugs Might Aid Weight Loss
TUESDAY, Jan. 10 (HealthDay News) -- A class of newer diabetes drugs that includes exenatide (Byetta, Bydureon) might also be used to help the obese lose weight, Danish researchers report.
 |
|
Free Diet Articles
|
